Juno Therapeutics Acquires AbVitro for $125,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    27 Drydock Ave 6th Floor Boston, MA 02116 USA
  • Company Description
    AbVitro is a venture backed next-generation antibody discovery focused on discovery of human-derived antibodies and biomarkers that are otherwise intractable using existing approaches.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Juno Therapeutics has acquired AbVitro of Boston for approximately $78 million in cash and almost 1.3 million shares of its stock, the company said.

Trending on Xconomy